What Should Temple Filler Restore in the Upper Face?

Reviewed against publicly available manufacturer and regulatory information plus peer-reviewed temple-augmentation studies. Last source review: July 24, 2026.

Quick Answer: Temple filler is used to restore volume when the visible concern is a true hollow in the temporal region at the sides of the upper face. It should not automatically be used for outer-brow descent, under-eye shadow, cheek volume loss, forehead contour, or general skin laxity. For many hyaluronic-acid temple plans, a practical consultation range is around 9 to 18 months: published HA studies show improvement from six months to beyond one year, and official Restylane Volyme information reports up to at least 18 months. Once true temple hollowing is confirmed, the clinic can keep JUVÉDERM and Restylane as two widely recognized international brand routes and add MONALISA and FLAWLESS as two distinct Korean CE-marked inventory routes.

Upper-Face Concern Routing Table

What the client says	What to assess first	What it means for the clinic
“The sides of my forehead look hollow.”	Whether the concavity is centered in the temporal fossa and changes the temple-to-cheek transition	This can enter a direct temple-volume assessment, followed by material, timeline, product, and pack selection.
“My outer brow has dropped.”	Brow position, frontalis and brow movement, skin laxity, and whether temporal hollowing is also present	Keep the brow or movement route separate. A temple-volume product is not an automatic answer to brow descent.
“The shadow is under my eye.”	Tear trough, orbital rim, lower-eyelid transition, and cheek support	Route to an under-eye or midface assessment; the location changes the product evidence and treatment plan.
“My cheek looks flat and the upper face looks tired.”	Whether the dominant volume change sits in the cheek, temple, or both as distinct regions	Create separate cheek and temple roles inside one facial-volume consultation instead of calling both “midface filler.”
“My face changed after major weight loss or illness.”	Local versus broader facial-volume change, skin quality, medical context, and stability	Use a broader facial assessment before selling a single-area syringe or multi-session program.
“I already had temple filler, surgery, or an implant.”	Exact material, date, surgery, current symptoms, and available records	Open a history or revision route before any new product is assigned.

The first decision is anatomical: is the concern truly in the temple? Only then should the clinic define the intended visual direction and decide which brand system, product family, pack format, and evidence route belong in the consultation.

Temple filler guide showing upper-face concern routing and four product roles

What Does Temple Filler Change?

The temporal region sits between the lateral forehead, outer brow, hairline, cheekbone, and upper cheek. When volume is reduced, the side of the upper face may look concave or more skeletal, and the transition from forehead to cheek can appear interrupted. The consultation goal is usually to reduce the dominance of that hollow and create a more continuous upper-face contour—not to make every temple completely flat.

A good temple-filler before-and-after comparison should use the same head position, lighting, expression, hairstyle, and camera distance. Front and oblique views are particularly useful because a profile alone may hide the width and location of the hollow. The clinic should describe an intended direction, such as a softer temple-to-cheek transition or less visible concavity, without promising perfect symmetry or a fixed degree of correction.

Location errors create purchasing errors. A shadow centered below the eye belongs to the Under-Eye Filler Guide. A flatter cheek or age-related midface loss belongs to the Cheek Filler Guide. Movement-led forehead lines or brow-position questions should use the Forehead and Upper-Face Concern Guide rather than being converted automatically into temple-volume demand.

Temple Filler vs Cheek Filler: Keep the Inventory Roles Separate

Decision point	Temple route	Cheek route	Procurement implication
Dominant location	Concavity at the lateral upper face between the forehead, outer brow, hairline, and cheekbone	Volume loss, projection, or contour demand centered in the midface and cheek	Route the dominant area first; do not assign a temple SKU because the patient uses the general phrase “upper-face volume.”
Intended visual direction	Less temporal concavity and a smoother forehead-to-cheek transition	Broader midface restoration, cheek definition, or a softer rounded cheek contour	Keep separate consultation language and service-menu codes even when one brand appears in both inventories.
Evidence question	What does the exact SKU and destination documentation support for the temple?	What does the exact SKU and destination documentation support for cheek or midface use?	Cheek evidence does not become temple evidence simply because the brand name or product family is familiar.

How Long Does Temple Filler Last?

For many hyaluronic-acid temple plans, a useful upfront range is around 9 to 18 months. This is a planning window, not a promise for every brand. A randomized VYC-20L temple study followed participants for 13 months and reported that treatment effects lasted for more than a year. Official Restylane Volyme material reports results lasting up to at least 18 months and specifically lists the temples among its treatment areas.

The useful distinction is between a planning range and a product promise. The VYC-20L trial belongs to the exact version studied, while the 18-month statement belongs to Restylane Volyme’s official product information. General cheek, contour, or facial-volume duration statements for other products should not be copied into a temple guarantee. The clinic should give the 9–18 month HA planning window first, then record the exact SKU and source used for that individual consultation.

Four Product and Inventory Routes for Confirmed Temple Hollowing

The matrix below does not rank products from best to worst. It keeps two recognized international HA brand routes and two Korean CE-marked HA routes in separate consultation and inventory roles. Exact documented indications are used only when they belong to the exact SKU and market; otherwise the copy states a manufacturer-positioned product role. FillersFairy product pages are used only for current pack and selector information.

VOLUMA evidence boundary: U.S. temple documentation belongs to the specific VOLUMA XC version. The supplied VOLUMA with Lidocaine presentation must be verified separately by destination market.

Exact SKU	Best-fit patient or clinic demand	Expected visual direction	Clinic inventory role	Pack format	Evidence type	Evidence details and boundary	Relevant destination-market check	What makes it different from the other three
JUVÉDERM VOLUMA with Lidocaine	A patient who asks for JUVÉDERM by name, or a clinic planning temple demand alongside cheek, chin, and broader facial volume	Immediate restoration of a visible hollow and a more continuous upper-face volume transition	Named JUVÉDERM multi-area volume route and two-syringe stock	Current FillersFairy listing: 2 × 1 mL	Regulatory/clinical evidence for the specific U.S. VOLUMA XC version; inventory role for the supplied VOLUMA with Lidocaine pack	The FDA temple documentation and VYC-20L trial apply to VOLUMA XC. They do not convert the supplied VOLUMA with Lidocaine presentation into the same documented version. The FillersFairy page supports only its current 2 × 1 mL pack fact.	Confirm the authorization and temple documentation for the exact VOLUMA with Lidocaine presentation supplied to the destination.	It is the only 2 × 1 mL JUVÉDERM route here and connects temple consultations with a broad named-brand facial-volume menu.
Restylane Volyme Lidocaine 1 mL	A patient seeking a soft, natural-looking transition or asking for a Restylane volume option	Immediate volume with a flexible temple-to-cheek transition that remains natural during expression	Restylane OBT volume menu and single-syringe HA route	Current FillersFairy listing: 1 × 1 mL with lidocaine	Manufacturer positioning plus product-specific temple and duration information; inventory role	Manufacturer-positioned role: official Restylane material lists the temples for Volyme, describes a soft and flexible volume gel, and reports results up to at least 18 months.	Match the exact Volyme presentation, local authorization, and supplied product documents to the destination market.	It gives the clinic a specifically named Restylane temple route, a 1 mL pack, and a soft-transition story distinct from VOLUMA’s two-syringe portfolio role.
MONALISA Hard with Lidocaine 1 mL	A patient asking for MONALISA, or a clinic that wants a compact Korean CE route connected to the GENOSS MONALISA product family	Controlled restoration of visible concavity and a smoother temple-to-cheek transition within a clinician-confirmed plan	GENOSS MONALISA family and 1 mL single-syringe Korean HA inventory	Current FillersFairy listing: 1 × 1 mL with lidocaine	Manufacturer positioning + CE/documentation support + inventory role	Manufacturer-positioned and CE-supported role: GENOSS positions MONALISA as a cross-linked HA facial product and publishes product-family quality data; its official history records European CE approval for MONALISA Lidocaine Filler. The FillersFairy page supplies the exact Hard pack fact.	Match the exact MONALISA Hard with Lidocaine label, CE documentation, and intended treatment information to the destination market.	It is the compact 1 mL GENOSS route, giving the clinic a Korean product-family choice that is separate from Restylane Volyme’s named temple positioning.
FLAWLESS Sub Q with Lidocaine, 2 × 1 mL	A patient asking for FLAWLESS, or a clinic that wants a Korean CE contour family and a two-syringe pack for temple and connected facial-volume demand	Broad restoration of a temporal hollow and a more continuous upper-face contour within a clinician-confirmed plan	FLAWLESS Fine/Deep/Sub Q family, Sub Q volume-and-contour role, and two-syringe Korean HA inventory	Current FillersFairy selector: Sub Q, 2 × 1 mL with lidocaine	Manufacturer positioning + CE/documentation support + inventory role	Manufacturer-positioned and CE-supported role: QUIVER MEDIC identifies FLAWLESS as its CE-certified face-filler line and lists Fine, Deep, and Sub Q within the range. The FillersFairy page supplies the exact selected variant and pack facts.	Match the exact FLAWLESS Sub Q label, CE documentation, and intended treatment information to the destination market.	It is the Korean 2 × 1 mL route and connects temple stock with a three-variant FLAWLESS contour family, rather than duplicating MONALISA Hard’s compact 1 mL role.

Official and research references used for this matrix: the FDA document for exact U.S. VOLUMA XC temple use, the VYC-20L temple trial, official Restylane Volyme information, the official GENOSS MONALISA product page, GENOSS approval history, and the official QUIVER MEDIC FLAWLESS product range. These are regulator, manufacturer, or academic sources—not competing supplier pages.

First Temple Filler Stock Decision

The first stock decision should begin with the clinic’s existing consultation and brand system, not with a claim that one product is universally superior.

Clinic’s current system	First stock route to assess	Why this route fits	When to expand
Existing JUVÉDERM portfolio	VOLUMA with Lidocaine	Maintains JUVÉDERM brand continuity and a 2 × 1 mL multi-area facial-volume inventory role, subject to separate destination verification for this supplied version	Add Volyme when Restylane demand becomes consistent, or add a Korean route when the clinic wants a separate CE brand and pack system.
Existing Restylane portfolio	Restylane Volyme	Keeps the clinic inside the Restylane volume family, provides a 1 mL stock route, and has official manufacturer material that specifically names the temples	Add VOLUMA for JUVÉDERM requests or a Korean HA route for a distinct brand, product-family, and pack option.
Korean HA expansion	MONALISA Hard and/or FLAWLESS Sub Q	MONALISA adds a compact GENOSS 1 mL route; FLAWLESS adds a 2 × 1 mL contour-family route. Both retain positive CE/documentation-supported roles.	Carry both when consultation demand and turnover justify two separate Korean brand systems rather than treating them as interchangeable.

Build the Temple Inventory Around the Service Menu

Service menu	Product combination	Patient demand covered	Purchasing conclusion
International Brand-Request Menu	VOLUMA + Restylane Volyme	Patients who request JUVÉDERM or Restylane and clinics building connected facial-volume portfolios	Keep both as fixed international routes: VOLUMA supplies the JUVÉDERM 2 × 1 mL portfolio role, while Volyme supplies the Restylane 1 × 1 mL soft-transition role.
Korean CE HA Menu	MONALISA Hard + FLAWLESS Sub Q	GENOSS/MONALISA brand demand and compact 1 mL stock, plus FLAWLESS family demand and a 2 × 1 mL contour pack	Carry both when the clinic serves both Korean brand systems; the buying reason is product family and pack planning, not a claim that one produces a universally better temple.
Compact Single-Syringe Menu	Restylane Volyme + MONALISA Hard	Clinics that need two clearly different 1 mL brand routes without committing every consultation to a two-syringe box	Use Volyme for the Restylane soft-transition and documented-temple story; use MONALISA Hard for a separate GENOSS Korean CE family and brand-request route.
Full Four-Role Menu	All four	Two international brand systems, two Korean CE brand systems, two single-syringe routes, and two two-syringe portfolio routes	Stock all four when consultation demand and turnover support each role. A smaller clinic can keep VOLUMA and Restylane as its international base, then add MONALISA, FLAWLESS, or both as Korean demand becomes visible.

What Determines Temple Filler Cost?

Temple filler cost varies because the consultation may lead to a 1 mL single-syringe route or a 2 × 1 mL multi-area pack. The visible degree and width of hollowing, bilateral planning, previous treatment, exact product, practitioner expertise, photography, and follow-up also affect the clinic’s quote. A universal online number would be less useful than stating which product and service scope the quote covers.

For the buyer, pack turnover matters as much as unit price. Restylane Volyme and MONALISA Hard support 1 mL single-syringe planning; VOLUMA and FLAWLESS Sub Q support different 2 × 1 mL international and Korean portfolio routes. The clinic should calculate stock against its actual consultation mix rather than treating all four boxes as interchangeable temple inventory.

How Should Clinics Set Temple-Filler Expectations?

The clinic can describe the intended visual direction—less concavity, a softer transition from forehead to cheek, or reduced skeletal shadow—but should not promise a perfectly flat temple, identical right and left sides, or a fixed duration. A successful consultation also explains why the selected brand and pack fit the patient’s request and the clinic’s wider facial-volume menu.

Adjacent regions should not be bundled without explanation. A patient may need a separate cheek assessment even when cheek volume affects the appearance of the temple. A patient asking about RADIESSE specifically can continue to the existing Can RADIESSE Treat Hollow Temples? article, while the JUVÉDERM VOLUMA Guide explains the broader VOLUMA volume role.

Temple Filler Safety and History Checks

The temple contains important blood vessels and lies near the orbit, so treatment belongs with a qualified professional who understands upper-face anatomy, patient selection, and complication management. Unexpected or escalating pain, skin that becomes pale, grey, blue, or unusually mottled, visual disturbance, severe headache, or neurological symptoms require immediate emergency assessment. Active infection, unexplained inflammation, an unknown previous filler, an implant, or significant prior surgery should be assessed before a new product is selected.

This guide intentionally does not provide injection points, dose, dilution, reconstitution, needle or cannula choice, or tissue-plane instructions. Those decisions must follow the exact product documentation and the judgement of an appropriately trained practitioner.

Frequently Asked Questions

Table of Contents

What does temple filler change?

Temple filler adds volume to a true temporal hollow at the sides of the upper face. The intended result is usually less visible concavity and a smoother transition from forehead to cheek. It does not automatically correct outer-brow descent, under-eye hollowing, cheek volume loss, forehead lines, or general skin laxity.

How long does temple filler last?

For many hyaluronic-acid temple plans, around 9 to 18 months is a useful consultation range. Published HA evidence shows improvement from six months to beyond one year, while official Restylane Volyme information reports results up to at least 18 months. The exact SKU, patient factors, and product-specific source should be stated with the estimate rather than turning the range into a guarantee.

How can I tell whether the hollow is in my temple, under-eye area, or cheek?

A temple hollow sits at the side of the upper face between the lateral forehead, outer brow, hairline, and cheekbone. A shadow centered below the lower eyelid belongs to the under-eye route, while flatter volume lower on the face belongs to the cheek or midface route. A clinician should assess the regions separately even when more than one contributes to a tired appearance.

Which inventory role matches the clinic’s patient demand?

Match the starting stock to the clinic’s existing system: VOLUMA supports JUVÉDERM and 2 × 1 mL facial-volume demand, Restylane Volyme supports a Restylane soft-transition and 1 mL route, MONALISA Hard adds a compact GENOSS Korean CE family, and FLAWLESS Sub Q adds a 2 × 1 mL Korean CE contour-family route. This is an inventory match, not a product ranking.

Can a clinic stock all four products in this guide?

Yes, when each SKU has a defined consultation and inventory role. VOLUMA and Restylane Volyme remain the clinic’s two international brand routes; MONALISA Hard adds a compact GENOSS 1 mL route, and FLAWLESS Sub Q adds a Korean 2 × 1 mL contour-family route. A smaller clinic can begin with JUVÉDERM and Restylane, then add one or both Korean brands as consultation demand and stock turnover justify expansion.

Choose the Next Route

The shadow is actually under the eye	Continue to the Under-Eye Filler Guide.
The dominant concern is cheek or midface volume	Use the Cheek Filler Guide and keep the cheek and temple roles distinct.
The patient asks specifically about CaHA	Continue to Can RADIESSE Treat Hollow Temples?.
The clinic has confirmed temple hollowing and defined a product role	Review the four product pages above or browse the Dermal Filler Collection, then request current pack, batch, expiry, and traceability documents for the exact SKU.

A clinic can stock all four products when each SKU has a defined role in the consultation and treatment menu. The objective is not to rank international and Korean brands from high to low, but to keep JUVÉDERM, Restylane, MONALISA, and FLAWLESS in four clear patient, brand, pack, and inventory roles.